Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × regramostim × Clear all

NCT02411786 2021-02-04

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Phase 1 Completed

Prostatic Neoplasms

NCT00582140 2019-11-19

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

Phase 1 Completed

Neoplasms, Prostatic Neoplasms